Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model

Background: Fasciolosis remains a significant food-borne trematode disease causing high morbidity around the world and affecting grazing animals and humans. A deeper understanding concerning the molecular mechanisms by which Fasciola hepatica infection occurs, as well as the molecular basis involved...

Full description

Autores:
Rojas Caraballo, Jose Vicente
López-Abán J.
Moreno-Pérez D.A.
Vicente B.
Fernández-Soto P.
Del Olmo E.
Patarroyo M.A.
Muro A.
Tipo de recurso:
Article of journal
Fecha de publicación:
2017
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/41822
Acceso en línea:
https://doi.org/10.16925/od.v0i0.429
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027580131&doi=10.1108%2fWWOP-04-2017-0010&partnerID=40&md5=f2320fcc84a313586badca0c12857a1c
https://hdl.handle.net/20.500.12494/41822
Palabra clave:
Fasciolosis
Vaccine
Epitope
Immunology
Microarrays
Gene expression
Rights
closedAccess
License
http://purl.org/coar/access_right/c_14cb
id COOPER2_bdbadb2a02730a04ea7d67083c9d6e72
oai_identifier_str oai:repository.ucc.edu.co:20.500.12494/41822
network_acronym_str COOPER2
network_name_str Repositorio UCC
repository_id_str
spelling Rojas Caraballo, Jose VicenteLópez-Abán J.Moreno-Pérez D.A.Vicente B.Fernández-Soto P.Del Olmo E.Patarroyo M.A.Muro A.2021-12-16T22:15:49Z2021-12-16T22:15:49Z2017https://doi.org/10.16925/od.v0i0.429https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027580131&doi=10.1108%2fWWOP-04-2017-0010&partnerID=40&md5=f2320fcc84a313586badca0c12857a1c14712334https://hdl.handle.net/20.500.12494/41822Rojas J,López J,Moreno DA,Vicente B,Fernández P,del Olmo E,Patarroyo MA,Muro A. Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model. BMC Infectious Diseases. 2017. 17. (1):p. 2-14. .Background: Fasciolosis remains a significant food-borne trematode disease causing high morbidity around the world and affecting grazing animals and humans. A deeper understanding concerning the molecular mechanisms by which Fasciola hepatica infection occurs, as well as the molecular basis involved in acquiring protection is extremely important when designing and selecting new vaccine candidates. The present study provides a first report of microarray-based technology for describing changes in the splenic gene expression profile for mice immunised with a highly effective, protection-inducing, multi-epitope, subunit-based, chemically-synthesised vaccine candidate against F. hepatica. Methods: The mice were immunised with synthetic peptides containing B- and T-cell epitopes, which are derived from F. hepatica cathepsin B and amoebapore proteins, as novel vaccine candidates against F. hepatica formulated in an adjuvant adaptation vaccination system; they were experimentally challenged with F. hepatica metacercariae. Spleen RNA from mice immunised with the highest protection-inducing synthetic peptides was isolated, amplified and labelled using Affymetrix standardised protocols. Data was then background corrected, normalised and the expression signal was calculated. The Ingenuity Pathway Analysis tool was then used for analysing differentially expressed gene identifiers for annotating bio-functions and constructing and visualising molecular interaction networks. Results: Mice immunised with a combination of three peptides containing T-cell epitopes induced high protection against experimental challenge according to survival rates and hepatic damage scores. It also induced differential expression of 820 genes, 168 genes being up-regulated and 652 genes being down-regulated, p value <0.05, fold change ranging from -2.944 to 7.632. A functional study of these genes revealed changes in the pathways related to nitric oxide and reactive oxygen species production, Interleukin-12 signalling and production in macrophages and Interleukin-8 signalling with up-regulation of S100 calcium-binding protein A8, Matrix metallopeptidase 9 and CXC chemokine receptor 2 genes. Conclusion: The data obtained in the present study provided us with a more comprehensive overview concerning the possible molecular pathways implied in inducing protection against F. hepatica in a murine model, which could be useful for evaluating future vaccine candidates. © 2017 The Author(s).josev.rojas@campusucc.edu.co14-2BioMed Central Ltd.FasciolosisVaccineEpitopeImmunologyMicroarraysGene expressionTranscriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine modelArtículohttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionBMC Infectious Diseasesinfo:eu-repo/semantics/closedAccesshttp://purl.org/coar/access_right/c_14cbPublication20.500.12494/41822oai:repository.ucc.edu.co:20.500.12494/418222024-08-20 16:21:48.587metadata.onlyhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.com
dc.title.spa.fl_str_mv Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model
title Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model
spellingShingle Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model
Fasciolosis
Vaccine
Epitope
Immunology
Microarrays
Gene expression
title_short Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model
title_full Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model
title_fullStr Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model
title_full_unstemmed Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model
title_sort Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model
dc.creator.fl_str_mv Rojas Caraballo, Jose Vicente
López-Abán J.
Moreno-Pérez D.A.
Vicente B.
Fernández-Soto P.
Del Olmo E.
Patarroyo M.A.
Muro A.
dc.contributor.author.none.fl_str_mv Rojas Caraballo, Jose Vicente
López-Abán J.
Moreno-Pérez D.A.
Vicente B.
Fernández-Soto P.
Del Olmo E.
Patarroyo M.A.
Muro A.
dc.subject.spa.fl_str_mv Fasciolosis
Vaccine
Epitope
Immunology
Microarrays
Gene expression
topic Fasciolosis
Vaccine
Epitope
Immunology
Microarrays
Gene expression
description Background: Fasciolosis remains a significant food-borne trematode disease causing high morbidity around the world and affecting grazing animals and humans. A deeper understanding concerning the molecular mechanisms by which Fasciola hepatica infection occurs, as well as the molecular basis involved in acquiring protection is extremely important when designing and selecting new vaccine candidates. The present study provides a first report of microarray-based technology for describing changes in the splenic gene expression profile for mice immunised with a highly effective, protection-inducing, multi-epitope, subunit-based, chemically-synthesised vaccine candidate against F. hepatica. Methods: The mice were immunised with synthetic peptides containing B- and T-cell epitopes, which are derived from F. hepatica cathepsin B and amoebapore proteins, as novel vaccine candidates against F. hepatica formulated in an adjuvant adaptation vaccination system; they were experimentally challenged with F. hepatica metacercariae. Spleen RNA from mice immunised with the highest protection-inducing synthetic peptides was isolated, amplified and labelled using Affymetrix standardised protocols. Data was then background corrected, normalised and the expression signal was calculated. The Ingenuity Pathway Analysis tool was then used for analysing differentially expressed gene identifiers for annotating bio-functions and constructing and visualising molecular interaction networks. Results: Mice immunised with a combination of three peptides containing T-cell epitopes induced high protection against experimental challenge according to survival rates and hepatic damage scores. It also induced differential expression of 820 genes, 168 genes being up-regulated and 652 genes being down-regulated, p value <0.05, fold change ranging from -2.944 to 7.632. A functional study of these genes revealed changes in the pathways related to nitric oxide and reactive oxygen species production, Interleukin-12 signalling and production in macrophages and Interleukin-8 signalling with up-regulation of S100 calcium-binding protein A8, Matrix metallopeptidase 9 and CXC chemokine receptor 2 genes. Conclusion: The data obtained in the present study provided us with a more comprehensive overview concerning the possible molecular pathways implied in inducing protection against F. hepatica in a murine model, which could be useful for evaluating future vaccine candidates. © 2017 The Author(s).
publishDate 2017
dc.date.issued.none.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2021-12-16T22:15:49Z
dc.date.available.none.fl_str_mv 2021-12-16T22:15:49Z
dc.type.none.fl_str_mv Artículo
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.coarversion.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.none.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.16925/od.v0i0.429
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027580131&doi=10.1108%2fWWOP-04-2017-0010&partnerID=40&md5=f2320fcc84a313586badca0c12857a1c
dc.identifier.issn.spa.fl_str_mv 14712334
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12494/41822
dc.identifier.bibliographicCitation.spa.fl_str_mv Rojas J,López J,Moreno DA,Vicente B,Fernández P,del Olmo E,Patarroyo MA,Muro A. Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model. BMC Infectious Diseases. 2017. 17. (1):p. 2-14. .
url https://doi.org/10.16925/od.v0i0.429
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85027580131&doi=10.1108%2fWWOP-04-2017-0010&partnerID=40&md5=f2320fcc84a313586badca0c12857a1c
https://hdl.handle.net/20.500.12494/41822
identifier_str_mv 14712334
Rojas J,López J,Moreno DA,Vicente B,Fernández P,del Olmo E,Patarroyo MA,Muro A. Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model. BMC Infectious Diseases. 2017. 17. (1):p. 2-14. .
dc.relation.ispartofjournal.spa.fl_str_mv BMC Infectious Diseases
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/closedAccess
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_14cb
eu_rights_str_mv closedAccess
rights_invalid_str_mv http://purl.org/coar/access_right/c_14cb
dc.format.extent.spa.fl_str_mv 14-2
dc.publisher.spa.fl_str_mv BioMed Central Ltd.
institution Universidad Cooperativa de Colombia
repository.name.fl_str_mv Repositorio Institucional Universidad Cooperativa de Colombia
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1808789303202938880